Ann Charlotte Akerblad

Summary

Affiliation: Pfizer Global Research and Development
Country: USA

Publications

  1. ncbi Effects of an educational compliance enhancement programme and therapeutic drug monitoring on treatment adherence in depressed patients managed by general practitioners
    Ann Charlotte Akerblad
    Department of Neuroscience, Psychiatry, Uppsala University Hospital, Uppsala University, Sweden
    Int Clin Psychopharmacol 18:347-54. 2003
  2. ncbi Response, remission and relapse in relation to adherence in primary care treatment of depression: a 2-year outcome study
    Ann Charlotte Akerblad
    Department of Neuroscience, Psychiatry, Uppsala University Hospital, Uppsala University, Sweden
    Int Clin Psychopharmacol 21:117-24. 2006
  3. ncbi Identification of primary care patients at risk of nonadherence to antidepressant treatment
    Ann Charlotte Akerblad
    Department of Neuroscience, Psychiatry, Uppsala University Hospital, Uppsala University, Uppsala, Sweden
    Patient Prefer Adherence 2:379-86. 2008
  4. ncbi Serum disposition of sertraline, N-desmethylsertraline and paroxetine: a pharmacokinetic evaluation of repeated drug concentration measurements during 6 months of treatment for major depression
    Margareta Reis
    Department of Medicine and Care, Division of Clinical Pharmacology, Faculty of Health Sciences, Linkoping University, Linkoping, Sweden
    Hum Psychopharmacol 19:283-91. 2004
  5. ncbi Compliance with SSRI medication during 6 months of treatment for major depression: an evaluation by determination of repeated serum drug concentrations
    Margareta Reis
    Division of Clinical Pharmacology, Linkoping University, Linkoping, Sweden
    J Affect Disord 82:443-6. 2004

Detail Information

Publications5

  1. ncbi Effects of an educational compliance enhancement programme and therapeutic drug monitoring on treatment adherence in depressed patients managed by general practitioners
    Ann Charlotte Akerblad
    Department of Neuroscience, Psychiatry, Uppsala University Hospital, Uppsala University, Sweden
    Int Clin Psychopharmacol 18:347-54. 2003
    ..This large study demonstrates that treatment response increases when using an educational compliance programme and that a strong relationship between treatment adherence and response exists...
  2. ncbi Response, remission and relapse in relation to adherence in primary care treatment of depression: a 2-year outcome study
    Ann Charlotte Akerblad
    Department of Neuroscience, Psychiatry, Uppsala University Hospital, Uppsala University, Sweden
    Int Clin Psychopharmacol 21:117-24. 2006
    ..In conclusion, this 2-year follow-up study showed superior long-term recovery in patients who were adherent to antidepressant medication compared to non-adherent patients...
  3. ncbi Identification of primary care patients at risk of nonadherence to antidepressant treatment
    Ann Charlotte Akerblad
    Department of Neuroscience, Psychiatry, Uppsala University Hospital, Uppsala University, Uppsala, Sweden
    Patient Prefer Adherence 2:379-86. 2008
    ..The purpose of this study was to identify predictors of nonadherence to antidepressant treatment that can be ascertained at treatment start...
  4. ncbi Serum disposition of sertraline, N-desmethylsertraline and paroxetine: a pharmacokinetic evaluation of repeated drug concentration measurements during 6 months of treatment for major depression
    Margareta Reis
    Department of Medicine and Care, Division of Clinical Pharmacology, Faculty of Health Sciences, Linkoping University, Linkoping, Sweden
    Hum Psychopharmacol 19:283-91. 2004
    ..For the future, continuous efforts are warranted to perform PK investigations in the natural clinical setting in which the drugs are usually prescribed...
  5. ncbi Compliance with SSRI medication during 6 months of treatment for major depression: an evaluation by determination of repeated serum drug concentrations
    Margareta Reis
    Division of Clinical Pharmacology, Linkoping University, Linkoping, Sweden
    J Affect Disord 82:443-6. 2004
    ..A recent estimation in a psychiatric cohort showed numbers of noncompliance between 10% and 60%. Therapeutic drug monitoring (TDM) is one method assessing compliance by analysis of drug concentration in the blood...